Acute diastolic (congestive) heart failure
Methodology & AI Transparency ⓘ
Acute diastolic (congestive) heart failure Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Under Heart & Cardiovascular Disease diagnostic criteria (I50.31), workup for Acute diastolic (congestive) heart failure integrates coronary perfusion imaging [Acute diastolic (congestive) heart failure I50.31] with evidence-graded therapy tailored to Apolipoprotein B (ApoB) [Acute diastolic (congestive) heart failure I50.31] response.
- 2 Real-world patient consensus: Mapped to Heart & Cardiovascular Disease under ICD-10-CM I50.31 for Acute diastolic (congestive) heart failure clinical workups.
- 3 Typical cash cost range: Differential triage of Acute diastolic (congestive) heart failure (I50.31) utilizes coronary perfusion imaging [Acute diastolic (congestive) heart failure I50.31].
- 4 Top reported side effects / signs: Objective lab/clinical target for Acute diastolic (congestive) heart failure: Apolipoprotein B (ApoB) [Acute diastolic (congestive) heart failure I50.31] (< 70 mg/dL (I50.31)) and Left Ventricular Ejection in Acute diastolic (congestive) heart failure (I50.31: Fraction (LVEF)).
Ask our AI Specialists anything about Acute diastolic (congestive) heart failure
What Is Acute diastolic (congestive) heart failure?
Under Heart & Cardiovascular Disease diagnostic criteria (I50.31), workup for Acute diastolic (congestive) heart failure integrates coronary perfusion imaging [Acute diastolic (congestive) heart failure I50.31] with evidence-graded therapy tailored to Apolipoprotein B (ApoB) [Acute diastolic (congestive) heart failure I50.31] response.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Acute diastolic (congestive) heart failure (ICD-10 I50.31) is driven by myocardial oxygen supply-demand in Acute diastolic (congestive) heart failure (I50.31: mismatch); specialists in Heart & Cardiovascular Disease monitor Left Ventricular Ejection in Acute diastolic (congestive) heart failure (I50.31: Fraction (LVEF)) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Acute diastolic (congestive) heart failure (I50.31): shortness of breath in Acute diastolic (congestive) heart failure (I50.31: when climbing stairs)
- • Secondary Acute diastolic (congestive) heart failure clinical sign: palpitations, skipped beats, in Acute diastolic (congestive) heart failure (I50.31: or irregular resting)
- • Symptom flares in Acute diastolic (congestive) heart failure correlating with Apolipoprotein B (ApoB) [Acute diastolic (congestive) heart failure I50.31] deviation outside < 70 mg/dL (I50.31)
- • Functional heart & vascular impact requiring coronary perfusion imaging [Acute diastolic (congestive) heart failure I50.31] evaluation (I50.31)
Acute diastolic (congestive) heart failure Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I50.31 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Heart & Cardiovascular Disease | NLM Clinical Tables |
| Diagnostic / Lab Marker: Apolipoprotein B (ApoB) [Acute diastolic (congestive) heart failure I50.31] | < 70 mg/dL (I50.31) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Left Ventricular Ejection in Acute diastolic (congestive) heart failure (I50.31: Fraction (LVEF)) | 55% – 70% (I50.31) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: NT-proBNP [Acute diastolic (congestive) heart failure I50.31] | < 100 pg/mL (I50.31) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Acute diastolic (congestive) heart failure
Treatment selection for Acute diastolic (congestive) heart failure depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Acute diastolic (congestive) heart failure)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| Can This Approach Help? Inside the Latest Research on Intermittent or Continuous kidney-Replacement Therapy in Acute Kidney New England Journal of Medicine, Volume 395, Issue 17 , Page 1677-1690, October 29, 2026. New England Journal of Medicine • 2026-10-14 • Peer-Reviewed Journal (Clinical Trials) | Multi-cohort | 97/100 | PMID NEJM-62256824 ↗ |
| New Insights on Baseline data, initial course, and management: losartan versus captopril: What a 5,477-Participant Study Found A total of 5,477 patients with heart failure during the acute phase or with a new Q-wave anterior infarction or reinfarction were recruited. The American journal of cardiology • 2001-03-15 • Randomized Controlled Trial | N = 5,477 | 96/100 | PMID 11249900 ↗ |
| New Insights on Reductions in acute medication use and healthcare resource utilization in: What a 1,113-Participant Study Found Treatment with galcanezumab resulted in significant reductions in headache medication overuse and migraine headache days requiring acute medication use, with notable reductions in migraine-specific HCRU. Journal of medical economics • 2022-01-15 • Phase III Randomized Trial | N = 1,113 | 96/100 | PMID 35971655 ↗ |
| New Insights on Evaluating the real-world benefits and safety of SpikoGen®, an: What a 4,219-Participant Study Found 12 657 and 4219 participants were randomized to the SpikoGen® and placebo group and followed for a median of 55 days (interquartile range, 48-60 days) and 51 days. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases • 2023-02-15 • Phase III Randomized Trial | N = 4,219 | 96/100 | PMID 36096430 ↗ |
| New Insights on Comparative Efficacy of Statins for Prevention of Contrast-Induced Acute Kidney: What a 6,385-Participant Study Found Results showed that statin loading before contrast administration was associated with a significantly reduced risk of CI-AKI in patients with CKD undergoing cardiac catheterization (odds ratio: 0.46; P < .05). Angiology • 2019-04-15 • Meta-Analysis | N = 6,385 | 94/100 | PMID 30261736 ↗ |
Acute diastolic (congestive) heart failure Patient Community & “People Like Me” Threads
Filter Acute diastolic (congestive) heart failure community threads and patient logs by age, biological sex, dosage, and treatment duration.